SABCS: Imlunestrant Tied to Improved PFS for ER-Positive, HER2-Negative Breast Cancer With ESR1 Mutations
Imlunestrant leads to significantly longer progression-free survival among those with ESR1 mutations, but not in overall population
ASH: Blinatumomab + Chemo Aids Survival in B-Cell Acute Lymphoblastic Leukemia
Estimated disease-free survival 97.5 ± 1.3 and 90.2 ± 2.3 percent with chemotherapy plus blinatumomab, chemo alone in average-risk patients
Spinal Manipulation Lowers Likelihood of Butalbital Rx With Tension-Type Headache
Similar pattern seen for medication overuse headache versus matched controls not receiving SMT
Dupilumab Efficacious for Atopic Dermatitis in Young Children
Findings seen for children with and without comorbidities, such as asthma, allergic rhinitis, food allergies
Metformin Beneficial in Lung Cancer Patients With Overweight, Obesity
Metformin correlates with progression-free survival in patients with overweight on immunotherapy
Benralizumab Beneficial for Eosinophilic Exacerbations of Asthma, COPD
Treatment failures occurred in significantly more patients receiving only prednisolone versus benralizumab
Women Report Less Poststroke Medication Adherence Than Men
Women more likely to report nonadherence to cholesterol-lowering drugs and antiplatelets
2011 to 2022 Saw Decline in Cost-Related Asthma Medication Nonadherence
Adults with asthma with cost-related medication nonadherence more likely to have asthma attacks, ED visits for asthma
Survival Up With Nivolumab + Ipilimumab Versus Chemo for Metastatic CRC
Findings seen in patients with microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancer
Radiotherapy With Adjuvant Durvalumab No Benefit for Head, Neck Cancer
No improvement seen in two-year progression-free survival for radiotherapy with durvalumab versus radiotherapy with cetuximab
